Skip to content

The Effect of Artificial Intelligence Chatbot and Expert Education on Breast Cancer Awareness Among Female Municipal Employees

The Effect of Artificial Intelligence Chatbot and Expert Education on Breast Cancer Awareness Among Female Municipal Employees: A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07749677
Enrollment
150
Registered
2026-08-06
Start date
2026-03-11
Completion date
2026-07-15
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Awareness

Keywords

Breast cancer awareness, Health education, Digital health literacy, Breast self-examination, Artificial intelligence chatbot

Brief summary

This study compared two educational approaches for increasing breast cancer awareness among female employees of Eskisehir Odunpazari Municipality. Participants were randomly assigned to receive education using artificial intelligence-generated educational material, education using expert-developed educational material, or no educational intervention. Breast cancer awareness was assessed at baseline, immediately after the intervention, and 2 months after the intervention. The study also assessed participants' digital health literacy.

Interventions

BEHAVIORALArtificial Intelligence Chatbot-Generated Educational Material

A structured educational material was generated using an artificial intelligence chatbot and presented through Google Forms in a conversational question-and-answer format. The content was written in plain language appropriate for female municipal employees aged 18 years or older and covered breast cancer risk factors, signs and symptoms, preventive attitudes, barriers to screening, awareness-related health behaviors, breast self-examination, and treatment methods. Participants accessed the predefined material through a link or QR code. No real-time or personalized chatbot interaction occurred. Both the artificial intelligence chatbot-generated educational material and the expert-developed educational material were evaluated by a panel of nine independent experts, comprising four general surgery specialists and five public health specialists.

BEHAVIORALExpert-Developed Educational Material

Breast cancer awareness educational material was developed by the researchers. The material covered breast cancer risk factors, signs and symptoms, preventive attitudes, barriers to screening, awareness-related health behaviors, breast self-examination, and treatment methods. It was evaluated by a panel of nine independent experts, comprising four general surgery specialists and five public health specialists.

Sponsors

Eskisehir Osmangazi University
Lead SponsorOTHER
Odunpazari Municipality
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Participants were informed about the general purpose of the study but were not informed of their assigned study group or the interventions provided to the other groups.

Intervention model description

This was a three-arm, parallel-group randomized controlled trial. Participants remained in their assigned group throughout the study.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Female employees actively working within Eskişehir Odunpazarı Municipality * Aged 18 years or older * Literate * Having a smartphone to access the digital educational material * Agreeing to participate in the study

Exclusion criteria

* Previous diagnosis of or treatment for breast cancer * Not having a smartphone * Being a healthcare professional * Not completing the study process

Design outcomes

Primary

MeasureTime frameDescription
Breast Cancer Awareness Scale Total ScoreBaseline, immediately after the intervention, and 2 months after the intervention.Overall breast cancer awareness was assessed using the Breast Cancer Awareness Scale, which consists of five subscales. Total scores range from 0 to 102, with higher scores indicating greater overall breast cancer awareness.

Secondary

MeasureTime frameDescription
Factor 1:Knowledge of Risk Factors ScoreBaseline, immediately after the intervention, and 2 months after the interventionKnowledge of breast cancer risk factors was assessed using the Knowledge of Risk Factors subscale of the Breast Cancer Awareness Scale. Scores range from 0 to 18, with higher scores indicating greater knowledge of breast cancer risk factors.
Factor 2: Knowledge of Signs and Symptoms ScoreBaseline, immediately after the intervention, and 2 months after the interventionKnowledge of breast cancer signs and symptoms was assessed using the Knowledge of Signs and Symptoms subscale of the Breast Cancer Awareness Scale. Scores range from 0 to 16, with higher scores indicating greater knowledge of breast cancer signs and symptoms.
Factor 3. Attitudes Toward Breast Cancer Prevention ScoreBaseline, immediately after the intervention, and 2 months after the interventionAttitudes toward breast cancer prevention were assessed using the Attitudes Toward Breast Cancer Prevention subscale of the Breast Cancer Awareness Scale. Scores range from 0 to 24, with higher scores indicating more positive attitudes toward breast cancer prevention
Factor 4. Barriers to Breast Cancer Screening ScoreBaseline, immediately after the intervention, and 2 months after the interventionPerceived barriers to breast cancer screening were assessed using the Barriers to Breast Cancer Screening subscale of the Breast Cancer Awareness Scale. Scores range from 0 to 16. Items are reverse-scored, with higher scores indicating fewer perceived barriers to breast cancer screening.
Factor 5. Health Behaviors Related to Breast Cancer Awareness ScoreBaseline, immediately after the intervention, and 2 months after the interventionHealth behaviors related to breast cancer awareness were assessed using the Health Behaviors Related to Breast Cancer Awareness subscale of the Breast Cancer Awareness Scale. Scores range from 0 to 28, with higher scores indicating more positive health behaviors related to breast cancer awareness.
Digital Health Literacy Instrument Total ScoreBaselineOverall digital health literacy was assessed using the 18-item Turkish version of the Digital Health Literacy Instrument, which consists of six subscales. The total mean score ranges from 1 to 4, with higher scores indicating greater digital health literacy.
DHLI Search ScoreBaselineSkills related to searching for online health information were assessed using the DHLI Search subscale. Mean scores range from 1 to 4, with higher scores indicating greater information-searching skills.
DHLI Content ScoreBaselineSkills related to adding self-generated content to digital health platforms were assessed using the DHLI Content subscale. Mean scores range from 1 to 4, with higher scores indicating greater content-adding skills.
DHLI Relevance ScoreBaselineSkills related to determining the relevance of online health information were assessed using the DHLI Relevance subscale. Mean scores range from 1 to 4, with higher scores indicating greater ability to determine the relevance of online health information.
DHLI Navigation ScoreBaselineSkills related to navigating online health information and digital health environments were assessed using the DHLI Navigation subscale. Mean scores range from 1 to 4, with higher scores indicating greater navigation skills.
DHLI Privacy ScoreBaselineSkills related to protecting personal privacy when using online health resources were assessed using the DHLI Privacy subscale. Mean scores range from 1 to 4, with higher scores indicating greater ability to protect personal privacy.
DHLI Reliability ScoreBaselineSkills related to evaluating the reliability of online health information were assessed using the DHLI Reliability subscale. Mean scores range from 1 to 4, with higher scores indicating greater ability to evaluate the reliability of online health information.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATOREZGİ SALIŞ, MD

Eskisehir Osmangazi University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026